Evidence map›Paper›PMID 28957756›Full record

ArticleThe International journal on drug policy2017

Using nominal group technique among clinical providers to identify barriers and prioritize solutions to scaling up opioid agonist therapies in Ukraine.

Lynn Madden, Martha J Bojko, Scott Farnum, Alyona Mazhnaya, Tatiana Fomenko, Ruthanne Marcus, Declan Barry, Irina Ivanchuk, Viktor Kolomiets, Sergey Filippovych and 2 more

Abstract read
In one paragraph

Article in The International journal on drug policy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lynn MaddenAPT Foundation, New Haven, CT, USA; Yale University School of Medicine, Department of Psychiatry, New Haven, CT, USA. Electronic address: LMadden@aptfoundation.org.
Martha J BojkoYale University School of Medicine, Section of Infectious Diseases, AIDS Program, New Haven, CT, USA.
Scott FarnumAPT Foundation, New Haven, CT, USA.
Alyona MazhnayaICF Alliance for Public Health, Kyiv, Ukraine.
Tatiana FomenkoICF Alliance for Public Health, Kyiv, Ukraine.
Ruthanne MarcusYale University School of Medicine, Section of Infectious Diseases, AIDS Program, New Haven, CT, USA.
Declan BarryAPT Foundation, New Haven, CT, USA; Yale University School of Medicine, Department of Psychiatry, New Haven, CT, USA.
Irina IvanchukUkrainian Centers for Disease Control, Kyiv, Ukraine.
Viktor KolomietsICF Alliance for Public Health, Kyiv, Ukraine.
Sergey FilippovychICF Alliance for Public Health, Kyiv, Ukraine.
Sergey DvoryakUkrainian Institute on Public Health Policy, Kyiv, Ukraine.
Frederick L AlticeAPT Foundation, New Haven, CT, USA; Yale University School of Medicine, Section of Infectious Diseases, AIDS Program, New Haven, CT, USA; Yale University School of Public Health, Division of Epidemiology of Microbial Diseases, New Haven, CT, USA; Centre of Excellence on Research in AIDS (CERiA), University of Malaysia, Kuala Lumpur, Malaysia.

Funding

Expanding Medication Assisted Therapy in Ukraine (ExMAT)R01DA033679 · NIDA · YALE UNIVERSITY · PI ALTICE, FREDERICK LEWIS · 2012 to 2021
$6.4M
NIDA NIH HHS R01 DA033679
6 · The paper itself

Abstract

backgroundOpioid agonist therapies (OAT) like methadone and buprenorphine maintenance treatment remain markedly under-scaled in Ukraine despite adequate funding. Clinicians and administrators were assembled as part of an implementation science strategy to scale-up OAT using the Network for Improvement of Addiction Treatment (NIATx) approach.

methodsNominal Group Technique (NGT), a key ingredient of the NIATx toolkit, was directed by three trained coaches within a learning collaborative of 18 OAT clinicians and administrators to identify barriers to increase OAT capacity at the regional "oblast" level, develop solutions, and prioritize local change projects. NGT findings were supplemented from detailed notes collected during the NGT discussion.

resultsThe top three identified barriers included: (1) Strict regulations and inflexible policies dictating distribution and dispensing of OAT; (2) No systematic approach to assessing OAT needs on regional or local level; and (3) Limited funding and financing mechanisms combined with a lack of local/regional control over funding for OAT treatment services.

conclusionsNGT provides a rapid strategy for individuals at multiple levels to work collaboratively to identify and address structural barriers to OAT scale-up. This technique creates a transparent process to address and prioritize complex issues. Targeting these priorities allowed leaders at the regional and national level to advocate collectively for approaches to minimize obstacles and create policies to improve OAT services.

Indexed as

BudgetsBuprenorphineDrug UsersHealth PolicyHIV InfectionsHumansMethadoneNarcoticsOpiate Substitution TreatmentOpioid-Related DisordersSubstance Abuse, IntravenousUkraineBuprenorphineMethadoneNarcoticsBuprenorphineImplementation scienceMethadoneNIATxNominal group techniqueOpioid agonist treatment (OAT)People who inject drugs (PWID)Structural barriersUkraine

Identifiers

PMID28957756
PMCPMC11884252

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.